BCC
ETON icon

Bridge City Capital’s Eton Pharmaceutcials ETON Stock Holding History

Bridge City Capital’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.19M Buy
88,132
+66,982
+317% +$1.96M 0.73% 55
2026
Q1 		$522K Buy
21,150
+2,550
+14% +$44.6K 0.14% 97
2025
Q4 		$315K Buy
18,600
+1,927
+12% +$33.9K 0.09% 103
2025
Q3 		$362K Buy
+16,673
New +$277K 0.1% 97

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Bridge City Capital's ETON Position: Q2 2026 in Review

Bridge City Capital increased its Eton Pharmaceutcials (ETON) stake by 317% in Q2 2026, buying an estimated $1.96M and bringing the position to 88,132 shares worth $3.19M. The position accounts for 0.73% of the portfolio, ranked #55.

Bridge City Capital first reported a position in ETON in Q3 2025 and has held it in 4 quarters since. 165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Bridge City Capital held 88,132 shares of Eton Pharmaceutcials worth $3.19M as of Q2 2026.
  • Bridge City Capital bought 66,982 Eton Pharmaceutcials shares in Q2 2026, an estimated $1.96M.
  • Eton Pharmaceutcials made up 0.73% of Bridge City Capital's portfolio in Q2 2026, its #55 holding.
  • Bridge City Capital first reported a position in Eton Pharmaceutcials in Q3 2025 and has held it in 4 quarters since.
  • 165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Bridge City Capital's 13F filing for Q2 2026, filed 11 Aug 2026.